Your browser doesn't support javascript.
loading
Body surface area-based dosing of 5-fluoruracil results in extensive interindividual variability in 5-fluorouracil exposure in colorectal cancer patients on FOLFOX regimens.
Saam, Jennifer; Critchfield, Gregory C; Hamilton, Stephanie A; Roa, Benjamin B; Wenstrup, Richard J; Kaldate, Rajesh R.
Affiliation
  • Saam J; Myriad Genetic Laboratories, Inc, Salt Lake City, UT, USA.
Clin Colorectal Cancer ; 10(3): 203-6, 2011 Sep.
Article in En | MEDLINE | ID: mdl-21855044
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Body Surface Area / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Precision Medicine Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Colorectal Cancer Journal subject: GASTROENTEROLOGIA / NEOPLASIAS Year: 2011 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Body Surface Area / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Precision Medicine Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Colorectal Cancer Journal subject: GASTROENTEROLOGIA / NEOPLASIAS Year: 2011 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos